Depression Awareness Monthly
0
  • Home
  • Latest News
  • Depression
Depression Awareness Monthly
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression
Latest News

Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes

Doctorslounge
Posted by Doctorslounge
Share on
READ NEXT
Midlife Deaths of Despair Increased From 1999 to 2022

More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone

Read More

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Doctorslounge
Previous Article Men Face Five to Seven Times Higher Rates of Firearm Deaths Than Women
Next Article Final Exams Don’t Have to Be High Stress for Your Teen

ADVERTISEMENT

ADVERTISEMENT

You Might Also Enjoy

Latest News

2021 to 2023 Saw Rise in Cannabis Use by Older Adults

Latest News

Text-Only, Health-Harm E-Cigarette Warnings Increase Beliefs in Addictiveness

Latest News

Judge Says Transgender Inmates Must Have Access to Hormone Therapy

Latest News

Dietary Patterns May Be Associated With Depressive Symptoms

Load More
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression

© 2020 - 2021 Powered by eHealthcare Solutions | Privacy Policy

×